Events

Time:  2:00PM-4:30PM
Location: Lobby

Register 
LabCentral residents email Clancy for free code

Program overview:
Will gene therapy become a reality in your lifetime? We have heard about gene therapy for decades, often with the promise of success. Modulating gene expression in vivo instead of undergoing surgery or taking drugs has been touted and doubted as the future of fighting diseases, but the tides have ebbed and flowed with many successes and failures.

Speakers:
Philip Gregory | CSO, Bluebird Bio 
Rob Kotin | VP, Virology & Gene Therapy, Voyager Therapeutics, Inc., Adjunct Professor, Gene Therapy Center, University of Massachusetts Medical School
Laura Sepp-Lorenzino | VP, Entrepreneur in Residence, Alnylam Pharmaceuticals 
[moderator] Charles Bridges | VP, Medical Devices, Cardiovascular Therapeutic Area Expert, Johnson and Johnson MD&D 

Agenda:
2:00 PM | Registration and Networking
2:30 PM | Presentations
3:15 PM | Panel discussion
4:00 PM | Networking Reception
4:30 PM | Program Close